Skip to main content
. 2024 Feb 16;16(2):281. doi: 10.3390/pharmaceutics16020281

Scheme 1.

Scheme 1

Design strategy for the RIV-IND hybrids [5a(1-3), 5b(1-3), 5c(1-3)] from templates with rivastigmine and indole (melatonin) derivatives.